logo-loader
NASDAQ:SEEL

Seelos Therapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$32.74 m
Price
$1.21
Change
0.83%
52 weeks high
12.82
52 weeks low
1.17

In brief

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.